A Potential New Target for ALS Therapies
The Context: Mutations in a gene called NEK1 are known to cause ALS in a subset of patients, but how exactly these mutations affect motor neurons...
News
The latest news and updates about NYSCF and our collaborators
6 Results
Clear Filters
Finding ALS Treatments That Work For All Patients
The Context: ALS is a disease that manifests differently in each patient, with some cases resulting from genetic predispositions, and others sporadically. Because the causes can...
How ‘Dancing Molecules’ Can Improve the Way We Study Neurodegenerative Disease
The Context: Turning patient stem cells into the different cell types of the brain offers immense promise for studying and treating neurodegenerative diseases such as Alzheimer’s,...
What are Stem Cells, and How Can They Accelerate Better Treatments for Disease?
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
Announcing The 2017 Class of NYSCF – Robertson Investigators
NYSCF welcomed six of the most talented stem cell researchers and neuroscientists from around the world into the NYSCF Investigator Program and the NYSCF Innovator Community....
Stem Cell Treatments
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...